HOME >> MEDICINE >> NEWS
Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer

CHICAGO, June 2, 2007 -- ALIMTA (pemetrexed for injection) showed additional utility in the treatment of the most diagnosed type of cancer , according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). Results from a Phase III study suggest that a first-line ALIMTA-based regimen may deliver less toxicity than a commonly used therapy in advanced non-small cell lung cancer (NSCLC). ALIMTA is manufactured and marketed by Eli Lilly and Company.

A prospective, randomized, multicenter Phase III study was conducted to compare ALIMTA plus carboplatin with the commonly used regimen of GEMZAR (gemcitabine HC1 for injection) plus carboplatin (ASCO Abstract # 7517 ). The study, conducted by the Norwegian Lung Cancer Group, enrolled 446 chemonave patients with either stage IIIB or IV NSCLC. The primary purpose of the study was to evaluate if the ALIMTA-carboplatin combination provided increased quality-of-life benefits while offering comparable survival data. As such, the primary endpoint was quality of life (defined in the study as nausea/vomiting; dyspnea or a difficulty in breathing, and; fatigue) and the secondary endpoint was overall survival.

Thus far, 384 patients have been analyzed for toxicity and there were fewer patients in the ALIMTA arm who experienced Grade 3/4 thrombocytopenia or a low platelet level (48 vs. 107, p<.001); leukopenia or a lowering of leukocyte white blood cells (44 vs. 89, p<.001), and; granulocytopenia or a lowering of granulocyte white blood cells (78 vs. 98, p=.02). More patients in the GEMZAR arm received transfusion of platelets (5 vs. 19, p=.02). At this point, no difference in survival has been observed.

The patients in this study received a comparable quality-of-life benefit whether they received ALIMTA and carboplatin or GEMZAR and carboplatin, said Bjrn Henning Grnberg, M.D. of St. Olavs University Hospital in Norway and the studys principal investigat
'"/>

Contact: Neil Hochman
n.hochman@cprworldwideusa.com
212-453-2067
CPR Worldwide
2-Jun-2007


Page: 1 2 3

Related medicine news :

1. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
2. Clinical review -- A psychological approach to the management of irritable bowel syndrome
3. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
4. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
5. Clinical guidelines for blood conservation during cardiac procedures developed
6. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
7. Clinical trial coordinators need more financial conflict-of-interest training
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... , ... April 18, 2019 , ... The Coro Medical ... the Sardis Volunteer Fire Department. , As a small, volunteer-only department in rural ... serve the community and now, is the only department with life-saving equipment of this ...
(Date:4/17/2019)... , ... April 17, 2019 , ... With Fentanyl overdose ... are working to curb the death toll by looking for an alternative to naloxone. ... National Meeting & Exposition this week. , Naloxone (often known by the name brand ...
(Date:4/17/2019)... ... April 17, 2019 , ... Ramneek Kumar Talwar and Vineet ... Gwangju, Korea, and has highly evaluated and confirmed iRINGER’s technology, a product that’s ... discussion of a potential partnership since then. , After sharing relevant ...
(Date:4/17/2019)... ... April 17, 2019 , ... Fertility Centers of Illinois ... an effort to unite millions of Americans aiming to remove the stigmas and ... initiative, Fertility Centers of Illinois is offering seven free physician-led webinars and free ...
(Date:4/17/2019)... ... April 17, 2019 , ... Cognition Corporation , a ... second installment of their two-part white paper series discussing ISO 13485:2016, the quality ... reviews some of the high-level changes to the standard identified in the ...
Breaking Medicine News(10 mins):
(Date:4/17/2019)... ... April 17, 2019 , ... To better address opioid ... and Gateway Health have launched a new program that takes a novel, holistic ... Enhanced Pain Management Program brings together a range of alternative, non-opioid therapies and ...
(Date:4/17/2019)... ... , ... Clinical trials of new cancer treatments have historically focused on disease ... advances in medical oncology and genomic characterization of tumors, we are now able to ... “basket trials.” This ability has created a paradigm shift in oncology trials. , In ...
(Date:4/17/2019)... ... April 17, 2019 , ... AdventHealth University (AHU) ... students to degrees in both a Master of Healthcare Administration in Strategy & ... to be completed in as little as two years with a total of ...
Breaking Medicine Technology:
Cached News: